Two Sigma Securities’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,789
Closed -$21K 2019
2025
Q4
$21K Buy
+11,789
New +$24.6K ﹤0.01% 1173
2022
Q1
Sell
-18,115
Closed -$55K 2374
2021
Q4
$55K Buy
+18,115
New +$68K ﹤0.01% 1262
2021
Q2
Sell
-2,508
Closed -$25K 1641
2021
Q1
$25K Buy
+2,508
New +$29.9K ﹤0.01% 769
2020
Q4
Sell
-712
Closed -$3K 1862
2020
Q3
$3K Sell
712
-1,044
-59% -$6.62K ﹤0.01% 1265
2020
Q2
$12K Buy
+1,756
New +$17.8K ﹤0.01% 1307
2019
Q2
Sell
-35
Closed -$4K 2318
2019
Q1
$4K Sell
35
-13
-27% -$1.68K ﹤0.01% 1752
2018
Q4
$6K Sell
48
-61
-56% -$9.69K ﹤0.01% 2049
2018
Q3
$18K Buy
+109
New +$17.3K ﹤0.01% 2456
2018
Q1
Sell
-6
Closed -$22K 2864
2017
Q4
$22K Buy
6
+5
+500% +$41.4K ﹤0.01% 1622
2017
Q3
$14K Buy
+1
New +$10.7K ﹤0.01% 856
2015
Q2
Hold
0
-$9K 235
2015
Q1
Hold
0
194

Other funds holding NSPR

Two Sigma Securities's NSPR Position: Q1 2026 in Review

Two Sigma Securities sold out of InspireMD (NSPR) in Q1 2026, closing a stake of 11,789 shares — an estimated $21K sold.

Two Sigma Securities first reported a position in NSPR in Q3 2017 and held it in 10 quarters. The position peaked at $55K in Q4 2021. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Two Sigma Securities reported no remaining InspireMD position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 11,789 InspireMD shares in Q1 2026, an estimated $21K.
  • Two Sigma Securities first reported a position in InspireMD in Q3 2017 and held it in 10 quarters.
  • Two Sigma Securities's InspireMD position peaked at $55K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.